H.C. Wainwright Reiterates Buy Rating on Marker Therapeutics (MRKR)
Tweet Send to a Friend
H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
